Healthcare Services

Narcolepsy Market Outlook 2026–2030 with Major Growth Drivers and Emerging Industry Trends

April 2, 2026April 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Narcolepsy Market At The End Of The 2026–2030 Forecast Period?

The narcolepsy market has experienced rapid expansion recently. Forecasts indicate its size will increase from $3.95 billion in 2025 to $4.38 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.8%. Historically, this growth stemmed from factors such as limited understanding of narcolepsy, prolonged diagnosis times, the common use of stimulant drugs, the introduction of sodium oxybate, and increased research into sleep disorders.

The narcolepsy market is anticipated to experience substantial expansion in the coming years. Its valuation is projected to reach $6.62 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.9%. This growth during the forecast period can be primarily attributed to factors such as an increasing incidence of sleep disorders, augmented investment in research and development, an expanding pipeline of non-stimulant therapies, a rise in patient education efforts, and progress in precision medicine strategies. Significant trends expected within the forecast timeframe encompass an uplifted awareness and improved diagnosis of narcolepsy, a greater uptake of combination therapies, an escalating need for long-acting treatments, an enlargement of non-stimulant alternatives, and a heightened emphasis on therapeutics specifically targeting cataplexy.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16491&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Narcolepsy Market?

The increasing count of individuals affected by obesity is projected to boost the expansion of the narcolepsy market in the future. This medical state, obesity, is marked by an overabundance of body fat, presenting a significant health hazard. The population suffering from obesity is expanding as a result of progressively inactive lifestyles, subpar eating routines, and environmental elements that encourage the intake of high-calorie foods and diminish physical movement. Disruptions in metabolic and hormonal equilibrium caused by obesity can foster narcolepsy, potentially altering sleep cycles and wakefulness control. For example, data from May 2025, reported by the Office for Health Improvement & Disparities, a government body in the UK, indicated that approximately 64.5 percent of adults aged 18 and above in England were classified as overweight or living with obesity during 2023–2024. This figure represents an increase from 64.0 percent in 2022–2023, signifying an ongoing increase. Consequently, the expanding population of obese individuals is stimulating the expansion of the narcolepsy market.

What Segment Types Make Up The Narcolepsy Market?

The narcolepsy market covered in this report is segmented –

1) By Type: Type 1, Type 2

2) By Treatment: Antidepressants, Stimulants, Sodium Oxybate, Other Treatments

3) By Diagnosis: Polysomnogram, Multiple Sleep Latency Test

Subsegments:

1) By Type 1: Stimulant Medications, Antidepressants, Sodium Oxybate, Immunosuppressive Treatments

2) By Type 2: Stimulant Medications, Sodium Oxybate, Antidepressants

What Industry Trends Are Redefining The Narcolepsy Market?

Companies operating in the narcolepsy market are increasingly concentrating on developing novel medications, such as extended-release sodium oxybate, to satisfy the growing demand for effective treatments. Extended-release sodium oxybate is a pharmaceutical agent utilized in the management of narcolepsy. This particular formulation facilitates the regulated release of the drug over an extended period, thereby delivering sustained symptom relief through the night and enhancing sleep quality for individuals living with narcolepsy. For example, in June 2023, Avadel Pharmaceuticals plc, an Ireland-based pharmaceutical firm, introduced LUMRYZ in the United States. LUMRYZ is an extended-release version of sodium oxybate that gained FDA approval for addressing cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. It marks the first and only once-at-bedtime oxybate treatment available for narcolepsy, signifying a considerable improvement over existing twice-nightly oxybate products by removing the necessity to wake up for a second dose during the night.

Who Are The Key Players Driving Competition In The Narcolepsy Market?

Major companies operating in the narcolepsy market are Pfizer Inc., Merck & Co. Inc, Novartis AG, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries, Otsuka Pharmaceutical, Sumitomo Pharma Company Limited, Jazz Pharmaceuticals, Alkermes, Harmony Biosciences, Cerevel Therapeutics, Axsome Therapeutics Inc., Avadel Pharmaceuticals, NLS Pharmaceutics AG, KemPharm, Bioprojet Pharma, Centessa Pharmaceuticals, Hikma Pharmaceuticals, Theranexus SA, Eisai Co Ltd, Ligand Pharmaceuticals, Graymark Healthcare Inc, H Lundbeck A/S

Read the full narcolepsy market report here:

https://www.thebusinessresearchcompany.com/report/narcolepsy-global-market-report

Which Regions Are Projected To Dominate The Narcolepsy Market In The Coming Years?

North America was the largest region in the narcolepsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the narcolepsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Narcolepsy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16491&type=smp

Browse Through More Reports Similar to the Global Narcolepsy Market 2026, By The Business Research Company

Core Materials Global Market Report

https://www.thebusinessresearchcompany.com/report/core-materials-global-market-report

Biomaterials Global Market Report

https://www.thebusinessresearchcompany.com/report/biomaterials-global-market-report

Biosurgery Global Market Report

https://www.thebusinessresearchcompany.com/report/biosurgery-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795